CoagulationDisorders near Scranton, PA

Biography: Dr. Timothy Wang is a leading expert in gastroenterology cancer research and patient care. His research specifically focuses on transgenic/ knockout mice, stem cells, lineage tracing, bone marrow-derived cells, and FACS analysis of immune/epithelial cells in the gut. His laboratory has for decades investigated the molecular mechanisms of gastrointestinal carcinogenesis, and has been continuously funded by the NIH for 29 years and by the NCI for 14 years. His lab has worked for many years on the role of inflammation in promoting gastrointestinal neoplasia, including colon cancer. His research has defined key roles for stromal cells in tumor development, including myeloid cells. Dr. Wang is the GI Division Chief at Columbia and serves as Co-leader of the Tumor Biology and Microenvironment Program of the Herbert Irving Comprehensive Cancer Center. He also serves as director of the Columbia University NCI U54 Tumor Microenvironment (TMEN) program and directs the Barretts Esophageal Translational Research Network (BETRNet) program and the Intestinal Stem Cell Consortium (ISCC) at Columbia. In addition to his leadership at Columbia, Dr. Wang has served as President of the American Gastroenterology Association (AGA). His work has been recognized with numerous awards, including the Outstanding Investigator Award from the NCI, the Irene and Arthur Fishberg Prize for medical research, the Ruth Leff Siegel Award for pancreatic cancer research, and the William Beaumont Prize in Gastroenterology from the AGA. Over his career, he has organized numerous conferences, including conferences on Gastrin, Regulatory Peptides, AACR Symposium on Gastric Cancer, Tumor Microenvironment, and Keystone Conferences.

Biography: Dr. Sathe completed her Residency in Internal Medicine at NYP/Weill Cornell and is a graduate of Rutgers-New Jersey Medical School. She also holds a JD from Columbia Law School. Her research focuses on improving cancer care delivery and reducing disparities in treatment and outcomes.

Biography: Dr. Lentzsch is a Professor of Clinical Medicine and the Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of Columbia University and at New York Presbyterian Hospital in New York. She is at New York Presbyterian Hospital/ Columbia University Medical Center. After receiving her degrees from the Humboldt University/ Charit Berlin, Germany, she completed her residency and fellowship at Humboldt University. She did a research fellowship, studying the mechanism of action of thalidomide and its derivatives in multiple myeloma, in the Jerome Lipper Multiple Myeloma Center under the mentorship of Dr Kenneth Anderson at the Dana-Farber Cancer Institute, Boston, MA, USA. Dr. Lentzsch was recruited in August 2004 to the University of Pittsburgh and University of Pittsburgh Cancer Institute (UPCI), PA, USA, and served as Clinical Director of the Multiple Myeloma Program at UPCI before accepting the position as Director of the Multiple Myeloma and Amyloidosis Program at Columbia University Medical Center. She cares primarily for patients with plasma cell dyscrasia including MGUS, Multiple Myeloma, Amyloidosis, POEMS and Waldenstrom's Macroglobulinemia. Dr. Lentzsch is an internationally recognized expert in the field of Multiple Myeloma and Amyloidosis. She serves as a SWOG Myeloma Committee Member, SWOG Study Coordinator and International Myeloma Foundation "Black Swan Research Initiative" committee member. She is a member of the standing advisory board for the evaluation of Secondary Primary Malignancies associated with IMiDs.

Biography: Dr. Henick is a medical oncologist specializing in the care of patients with malignancies of the aerodigestive tract.As the Associate Director of Experimental Therapeutics and Director of Translational Research in Aerodigestive Cancers in Medical Oncology, Dr. Henick's clinical care and research are aligned to improve the effectiveness of, and limit toxicity from, emerging cancer treatments. These effortsentail clinical trials that Dr. Henick has written and leads to study novel therapeutic approaches and to reduce steroid dependence among patients experiencing adverse events fromimmunotherapy.

Biography: Meghna S. Trivedi, MD, MS cares for patients diagnosed with breast cancer. Dr. Trivedi received her medical degree from the University of Maryland School of Medicine, and completed her residency at the University of Pennsylvania. She went on to complete her fellowship in hematology/oncology at Columbia University. Dr. Trivedi co-leads the Hereditary Breast and Ovarian Cancer Program, a comprehensive, multi-disciplinary initiative aimed at screening, preventing, diagnosing, and treating hereditary breast and ovarian cancer. This innovative program brings together the resources of a world-renowned academic institution, including cutting-edge genomic testing, clinical trials, and experts in hereditary cancers across different specialties. Dr. Trivedi's research and care expertise also includes cancer genetics and genomics, precision medicine, and chemotherapy induced peripheral neuropathy. She is the principal investigator on several clinical trials, and has authored numerous publications in leading peer-reviewed journals. Dr. Trivedi is a member of the American Society of Clinical Oncologists and SWOG.

Biography: Dr. Vaibhav Patel, MD is a Hematology Specialist who practices in New York, NY. He is 38 years old. Dr. Vaibhav Patel, MD is affiliated with Mount Sinai Queens, Mount Sinai Brooklyn and Mount Sinai Hospital.

Biography: Dr. Sheen is the Medical Director of Labor and Delivery at NewYork-Presbyterian/Columbia University Irving Medical Center. She entered the field of maternal-fetal medicine after an established career in general obstetrics and gynecology and education, having received her medical degree from the New York University School of Medicine and followed with residency training in obstetrics and gynecology at NewYork-Presbyterian Hospital/Weill Cornell Medical College. She then practiced general obstetrics and gynecology and was the Associate Residency Director at Jamaica Hospital Medical Center prior to pursuing her fellowship in Maternal-Fetal Medicine (MFM) at Albert Einstein College of Medicine/Montefiore Medical Center. Her experience with varying maternal medical and fetal disorders contributed to her interest in pursuing formal training in perinatology. During fellowship, Dr. Sheen continued her work with maternal medical disorders, obstetrics and gynecology education, patient safety and the quality assessment of patient care, besides developing her interests in evaluating fetal anomalies. Her research and interests have included studies of progesterone use in preventing preterm labor in patients with varying medical co-morbidities, radiologic imaging for evaluating pulmonary emboli in pregnancy, postpartum emergency room utilization, epigenetics of diabetes and obesity, as well as patient safety and resident education through simulation/hand-off training.

Biography: Stephanie Purisch, MD is a maternal-fetal medicine specialist and assistant professor of obstetrics and gynecology at Columbia University Irving Medical Center. She joined the Division of Maternal-Fetal Medicine at Columbia after completing residency in obstetrics and gynecology at the Hospital of the University of Pennsylvania and fellowship in maternal-fetal medicine at Columbia University. Dr. Purisch is the co-director of the Mothers Center Heart Program, which provides comprehensive, multidisciplinary clinical care to women with cardiovascular disease who are pregnant or contemplating pregnancy. Dr. Purisch's primary clinical and research interest is the care of women with medically complicated pregnancies. In addition to cardiac disease in pregnancy, she also has expertise caring for pregnant women with underlying maternal pulmonary, endocrine, rheumatologic, and hematologic diseases.

Biography: Blair Johnson Wylie, MD, MPH, is the Founding Director of The Collaborative for Women's Environmental Health at Columbia University and the Virgil G. Damon Professor of Obstetrics and Gynecology at Columbia's Vagelos College of Physicians and Surgeons. She also serves as the obstetric consultant to Region 1's Pediatric Environmental Health Specialty Network (PEHSU). Dr. Wylie received her bachelor's degree from Princeton University and her medical degree from Harvard Medical School. She studied epidemiology at the Columbia University Mailman School of Public Health, where she received her master's in public health. She completed her residency in Obstetrics and Gynecology at the University of Washington Medical Center and a fellowship in Maternal-Fetal Medicine at Columbia University. Dr. Wylie's clinical practice encompasses the full range of maternal-fetal medicine, including prenatal diagnosis and ultrasound, high risk obstetric conditions, caring for pregnant women hospitalized during pregnancy, and deliveries. She also offers women and their families consultation about how environmental exposures can impact the health of pregnancy and the developing fetus. In addition to her clinical and administrative roles, Dr. Wylie conducts research with a focus on global maternal/child health, with a particular interest in environmental exposures during pregnancy in international settings, such as smoke from cooking fires, pesticides from subsistence farming, and climate-related factors like heat and air pollution. She has ongoing projects in Ghana, Tanzania, Pakistan and India. She is co-Principal Investigator for Columbia University/Aga Khan University Research Unit in the Eunice Kennedy Shriver National Institute of Child Health and Human Development's Global Network for Women's and Children's Health Research. She previously chaired the Society for Maternal-Fetal Medicine's Global Health Committee and now chairs the Foundation for SMFM's Queenan Fellowships for Global Health. Additionally, she recently completed a three-year term on the Board for the Society for Maternal-Fetal Medicine.

Biography: Maria Andrikopoulou MD, PhD is a maternal-fetal medicine specialist and Assistant Professor of Obstetrics and Gynecology at Columbia University Irving Medical Center. She joined the Division of Maternal-Fetal Medicine at Columbia after completing her residency in Obstetrics and Gynecology at NYU Winthrop University Hospital, and fellowship in Maternal-Fetal Medicine at Columbia University. Dr. Andrikopoulou specializes in the care of high-risk pregnancies, including women with medical complications and fetal anomalies. Her primary clinical and research interests include prenatal diagnosis, sonographic evaluation of fetal malformations and fetal echocardiogram. Dr. Andrikopoulou has presented at many national conferences and published several peer-reviewed research manuscripts and book chapters, focusing on clinical obstetrics, fetal ultrasound and perinatal epidemiology. She is a member of the American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine and International Society of Ultrasound in Obstetrics and Gynecology.

Biography: Dr. Laura S. Munoz Arcos is an Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine and an Assistant Attending Physician at NewYork-Presbyterian Hospital.Dr. Munoz Arcos earned her medical degree from Universidad del Valle in Colombia, her home country. She then completed an internal medicine residency at Montefiore Medical Center/Albert Einstein College of Medicine in the Bronx, NY, followed by a Hematology and Oncology fellowship at Weill Cornell Medicine/NewYork-Presbyterian Hospital, where she served as Chief Fellow in her final year. During her fellowship, Dr. Munoz Arcos gained extensive clinical experience in treating all types of breast cancer while conducting translational research on liquid biopsy in breast cancer at Dr. Massimo Cristofanilli's laboratory. Her research focuses on identifying predictors of response to therapy in hormone receptor-sensitive metastatic breast cancer. In recognition of her work, she received the 2023 Conquer Cancer American Society of Clinical Oncology (ASCO) Young Investigator Award, a prestigious honor granted to only 100 recipients annually. Following the completion of her fellowship, Dr. Munoz Arcos joined the Division of Hematology and Medical Oncology as a faculty member, where she is focused on the treatment of breast cancer.

Biography: Dr. Vladimir Limonnik, DO is an Oncology Specialist who practices in Philadelphia, PA. He is 36 years old and has been practicing for 7 years. Dr. Vladimir Limonnik, DO is affiliated with Jefferson Torresdale Hospital.

Biography: Dr. Aneela Ali, MD is an Oncology Specialist who practices in Philadelphia, PA. Dr. Aneela Ali, MD is affiliated with Jefferson Torresdale Hospital.

Biography: Dr. Bobak Parang completed his undergraduate studies at the University of Pennsylvania, where he majored in Biology. He subsequently earned his MD and PhD from Vanderbilt University School of Medicine. He then joined the Weill Cornell Medicine Physician Scientist Training Program where he completed his internal medicine residency and hematology / medical oncology fellowship. During his last year of fellowship, Dr. Parang served as Chief Fellow. As a member of the Weill Cornell Medicine faculty, Dr. Parang is a physician-scientist whose clinical and research interests are focused on lung cancer drug resistance and metastases.

Biography: Caitlin Gribbin, MD, is an Instructor in Medicine within the Division of Hematology and Oncology at Weill Cornell Medical Center. After earning her B.A. from Cornell University, Dr. Gribbin received her Medical Degree as well as Masters in Science from Weill Cornell Medical College. She completed her Internship and Residency as well as subsequent Fellowship training in Hematology and Oncology within the Medical Research Track at Weill Cornell Medicine/NewYork-Presbyterian Hospital. As a faculty member at Weill Cornell, Dr. Gribbin specializes in treating patients with lymphoma using cellular therapies, including chimeric antigen receptor (CAR) T cell therapy. She is simultaneously focused on leading clinical and translational research studies aimed at improving lymphoma treatments by bringing novel scientific discoveries to patients. Dr. Gribbin has co-authored numerous publications and presentations at national and international meetings and has received several research grants, including the American Society of Clinical Oncology (ASCO) Young Investigator Award, the Lymphoma Research Foundation (LRF) Scientific Research Mentoring Program Award, and the Burroughs Wellcome Fund Award.

Biography: Dr. Evelyn Cantillo completed her undergraduate studies at Cornell University prior to pursuing a Master of Public Health degree at Columbia University. She subsequently earned a medical degree at the Albert Einstein College of Medicine, graduating with special distinction in Obstetrics and Gynecology. Her residency training in Obstetrics and Gynecology was completed at Tulane University, followed by a fellowship in Gynecologic Oncology and Breast Disease at the Women & Infants Hospital/Brown University.Dr. Cantillo's practice encompasses the surgical and medical management of the broad spectrum of gynecologic malignancies including uterine, ovary, cervix, vulva, and vagina. She is extensively trained in minimally invasive surgical techniques using traditional laparoscopy, as well as robotic platforms, for gynecologic cancer and complex benign conditions.Dr. Cantillo believes that every woman with gynecologic cancer should have access to the full complement of care. With this in mind, her aim is to expand access to clinical trials should this become necessary. She is a member of the New Investigators Committee of the national NRG (formerly Gynecologic Oncology Group/GOG). It's important to her that all populations be afforded the same opportunities and treatment.Her interests also include medical education. She has received numerous teaching and surgical awards during residency and fellowship training and has presented her research at regional and national conferences.

Biography: After earning a medical degree from Yale University School of Medicine, Dr. Overton completed both her residency and her fellowship in Maternal-Fetal Medicine at NewYork-Presbyterian Columbia University Irving Medical Center (CUIMC). Dr. Overton's clinical and research interests include placenta accreta spectrum disorder, management and prevention of obstetric surgical complications, care of patients with prior poor obstetric outcomes and preterm birth prevention. She has ample experience and training in diagnostic ultrasound screening and procedural testing, including amniocentesis and chorionic villus sampling.